Objectives
Musculoskeletal ultrasonography (US) has been an established modality for the diagnosis of gout and possible evaluation of efficacy of urate-lowering therapy (ULT). To enhance its clinical importance and reliability, it would be important to know whether patient’s history and parameters of gout are related to monosodium urate deposition on US images.
Methods
We searched for eligible patients in our electronic patient database, based on the keywords of gout and hyperuricemia during the years 2007-2018. We then examined their medical history, uric acid excretion marker, serial data of serum uric acid (UA), renal function, dosage of ULT drugs, and US findings on gout flare. This study protocol was a retrospective descriptive one approved by our hospital ethical committee and carried out in accordance with the Declaration of Helsinki.
Results
A total of 72 patients (15 female, 57 male) were selected from our database search. US was timely undertaken for 28 of those patients (4 female, 24 male) who had experienced gout flare. Double contour sign (DCS) was found in 23 patients (4 female, 19 male; DCS group) and hyperechoic aggregate without DCS was shown in the other 5 patients (all male; non-DCS group). We compared duration after notice of hyperuricemia/gout, previous gout attack experience, initial serum uric acid (UA), fractional excretion of UA (FEUA), BMI and eGFR for the groups. The duration after notice of hyperuricemia was significantly longer in the DCS group than non- DCS (DCS; 5.9 years, non- DCS; 1.8 years, p=0.0103). Moreover, the DCS group had experienced one or more previous gout attack episodes than the non-DCS group. No other clinical parameters were significantly different between the two groups. Presence of hyperechoic aggregate (HAG) findings was not related to any clinical parameter. Therefore, the processes of development of the two US findings seemed to be different from each other, although both DCS and HAG represented articular monosodium urate deposition.
Conclusion
DCS and /or HAG findings are frequently shown in US on a gouty attack and DCS may develop some years after the onset of hyperuricemia.
View full abstract